Evidence map›Paper›PMID 33297727›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Prognostic Significance of Lactate Dehydrogenase in Patients Undergoing Surgical Resection for Laryngeal Squamous Cell Carcinoma.

Erliang Guo, Lunhua Guo, Changming An, Cong Zhang, Kaibin Song, Guohui Wang, Chunbin Duan, Xiwei Zhang, Xianguang Yang, Zhennan Yuan and 8 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Erliang GuoDepartment of Surgery, The 2nd Affiliated Hospital of Harbin Medical University, Harbin 150081, China.
Lunhua GuoDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Changming AnDepartment of Head and Neck Surgery, Chinese National Cancer Center & Chinese Academy of Medical Sciences Cancer Hospital. Beijing 100000, China.
Cong ZhangDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Kaibin SongDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Guohui WangDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Chunbin DuanDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Xiwei ZhangDepartment of Head and Neck Surgery, Chinese National Cancer Center & Chinese Academy of Medical Sciences Cancer Hospital. Beijing 100000, China.
Xianguang YangDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Zhennan YuanDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Junnan GuoDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Ji SunDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Hongxue MengDepartment of Pathology, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Rui ChangDepartment of Head and Neck Surgery, Anyang Cancer Hospital, Anyang 455000, China.
Xiaomei LiDepartment of Pathology, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Cheng XiuDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Xionghui MaoDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.
Susheng MiaoDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin 150081, China.ORCID https://orcid.org/0000-0002-7701-9362
Harbin Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNAnyang Tumor Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim is to estimate the prognostic value of lactate dehydrogenase (LDH) in patients undergoing surgical resection for laryngeal squamous cell carcinoma (LSCC). A total of 640 resected LSCC patients were included. Preoperative lactate dehydrogenase (LDH) was assessed. Kaplan-Meier survival analysis and Cox regression analysis were conducted for overall survival (OS) and recurrence-free survival (RFS). Kaplan-Meier analysis, univariate analysis and multivariate analysis demonstrated significant prognostic value for preoperative LDH. Although LDH was predictor of OS, it failed to be a predictor of RFS. The univariate HR and 95% CI of LDH were 0.484 and 0.357-0.658 (P < 0.0001). The multivariate analysis showed that LDH (HR = 0.518, 95% CI: 0.380-0.705, p < 0.0001) was related to OS. Elevated preoperative LDH >132 IU/L was significantly associated with better survival. Preoperative LDH might be an independent prognostic marker of OS in LSCC patients undergoing surgical resection.

Indexed as

AgedBiomarkers, TumorDisease-Free SurvivalFeasibility StudiesFemaleHumansKaplan-Meier EstimateLaryngeal NeoplasmsLaryngectomyLarynxL-Lactate DehydrogenaseMaleMiddle AgedNeoplasm Recurrence, LocalPredictive Value of TestsPreoperative PeriodBiomarkers, TumorL-Lactate Dehydrogenaselactate dehydrogenaselaryngeal canceroverall survivalprognosisrecurrence-free survival

Identifiers

PMID33297727
PMCPMC8480349
OpenAlexW3112465641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.